Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Return on Assets (2016 - 2018)

Historic Return on Assets for Soleno Therapeutics (SLNO) over the last 5 years, with Q3 2018 value amounting to 0.02%.

  • Soleno Therapeutics' Return on Assets rose 1300.0% to 0.02% in Q3 2018 from the same period last year, while for Sep 2018 it was 0.02%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.04% for FY2018, which is 1200.0% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Return on Assets of 0.02% as of Q3 2018, which was up 1300.0% from 0.05% recorded in Q2 2018.
  • Soleno Therapeutics' 5-year Return on Assets high stood at 0.02% for Q3 2018, and its period low was 1.84% during Q4 2014.
  • Its 5-year average for Return on Assets is 0.87%, with a median of 1.12% in 2015.
  • Per our database at Business Quant, Soleno Therapeutics' Return on Assets tumbled by -4400bps in 2016 and then soared by 15000bps in 2017.
  • Quarter analysis of 5 years shows Soleno Therapeutics' Return on Assets stood at 1.84% in 2014, then grew by 15bps to 1.57% in 2015, then skyrocketed by 30bps to 1.09% in 2016, then soared by 90bps to 0.11% in 2017, then soared by 85bps to 0.02% in 2018.
  • Its Return on Assets stands at 0.02% for Q3 2018, versus 0.05% for Q2 2018 and 0.07% for Q1 2018.